1st Quarter - Report

HIGHMARK, INC. for HIGHMARK INC

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Insulin, Drug Pricing, Drug Patent Reform, Pharmacy Benefit Manager (PBM) Reform H.R. 1488/S. 954 - The Affordable Insulin Now Act A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals. S. 127. - The Pharmacy Benefit Manager Transparency Act A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes. S. 142 -- The Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.

LobbyistCovered position, as disclosed
GREGORY P ENGLERT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 127 (118th), S. 954 (118th), H.R. 1488 (118th), S. 142 (118th)

Health Issues HCR

Affordability of Coverage, Telehealth, COVID/End of Public Health Emergency, Mental Health, Workforce Shortages, Site-Neutral Payments, Social Determinants of Health, Medical Loss Ratio H.R. 1843/S. 1001 - The Telehealth Expansion Act A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules.

LobbyistCovered position, as disclosed
GREGORY P ENGLERT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1001 (118th), H.R. 1843 (118th)

Medicare/Medicaid MMM

Medicare Advantage Rate Notice, Risk Adjustment, Star Ratings, Medicare Advantage RADV Rule, Prior Authorization in Medicare Advantage, Medicaid Redeterminations, Site Neutral Payments, Social Determinants of Health S. 1002 -- No UPCODE Act A bill to amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage.

LobbyistCovered position, as disclosed
GREGORY P ENGLERT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1002 (118th)

Taxation/Internal Revenue Code TAX

Amortization of Research and Experimental Expenditures S. 866 - The American Innovation and Jobs Act A bill to amend the Internal Revenue Code of 1986 to enhance tax benefits for research activities.

LobbyistCovered position, as disclosed
GREGORY P ENGLERT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 866 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.